STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7
Clinical trials for STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy-Chemo cocktail shows promise for mesothelioma before surgery
Disease control OngoingThis early-phase trial tested whether giving a combination of immunotherapy (atezolizumab) and chemotherapy (cisplatin and pemetrexed) before surgery, followed by more immunotherapy after surgery, is safe and feasible for people with resectable malignant pleural mesothelioma. The…
Matched conditions: STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 16:06 UTC
-
New drug cocktail offers hope for rare cancers
Disease control OngoingThis study tests a combination of two drugs, atezolizumab and bevacizumab, in people with rare solid tumors that are hard to treat. The goal is to see if the drugs can shrink or control the cancer by boosting the immune system and blocking tumor blood supply. About 133 adults wit…
Matched conditions: STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:50 UTC